Abstract
Considering promising results in animal models and patients, therapeutic use of MSCs for immune disease is likely to undergo continued evaluation. Low-lever laser (LLL) has been widely applied to retard the inflammatory reaction. LLL treatment can potentially be applied in anti-inflammatory therapy followed by regenerative medicine therapy.
Kan Yin, Rongjia Zhu, Shihua Wang, Robert Chunhua Zhao
